Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The use of the listed lots for these sensititre broth could produce out of specification high qc results (false resistance) for the antibiotic tigecycline with qc organism enterococcus faecalis. the risk associated with false resistance to the antibiotic would be potential delay in reporting therefore the risk associated with this incident is considered low.